脂质代谢
可药性
铜
铜缺乏
新陈代谢
生物
生物化学
脂肪肝
铜代谢
发病机制
疾病
化学
内科学
医学
基因
免疫学
有机化学
作者
Bryce Blades,Scott Ayton,Ya Hui Hung,Ashley I. Bush,Sharon La Fontaine
标识
DOI:10.1016/j.bbagen.2021.129979
摘要
Copper and lipid metabolism are intimately linked, sharing a complex, inverse relationship in the periphery (outside of the central nervous system), which remains to be fully elucidated.Copper and lipids have independently been implicated in the pathogenesis of diseases involving dyslipidaemia, including obesity, cardiovascular disease and non-alcoholic fatty liver disease and also in Wilson disease, an inherited disorder of copper overload. Here we review the relationship between copper and lipid regulatory pathways, which are potential druggable targets for therapeutic intervention.While the inverse relationship between copper and lipids is apparent, tissue-specific roles for the copper regulatory protein, ATP7B provide further insight into the association between copper and lipid metabolism.Understanding the relationship between copper and lipid metabolism is important for identifying druggable targets for diseases with disrupted copper and/or lipid metabolism; and may reveal similar connections within the brain and in neurological diseases with impaired copper and lipid transport.
科研通智能强力驱动
Strongly Powered by AbleSci AI